Silodosin

drugbox
IUPAC_name = 1-(3-hydroxypropyl)-5- [(2R)- 2- [2- [2-(2,2,2-trifluoroethoxy) phenoxy] ethylamino] propyl] -7-indolinecarboxamide


CAS_number = 160970-54-7
ATC_prefix =
ATC_suffix =
PubChem = 5312125
DrugBank =
C = 25 |H = 33 |F = 3 |N = 3 |O = 4
molecular_weight = 495.534g/mol
smiles = Clc1ccc2ccc(/C=C/c3cccc(c3)C(CCc3ccccc3C(C)(C)O)SCC3(CC3)CC(=O)O)nc2c1
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_category =
legal_status =
routes_of_administration = Oral

Silodosin is an α1-adrenoceptor antagonistcite journal |author=Yoshida M, Homma Y, Kawabe K |title=Silodosin, a novel selective alpha 1A-adrenoceptor selective antagonist for the treatment of benign prostatic hyperplasia |journal=Expert Opin Investig Drugs |volume=16 |issue=12 |pages=1955–65 |year=2007 |month=December |pmid=18042003 |doi=10.1517/13543784.16.12.1955 |url=http://www.expertopin.com/doi/abs/10.1517/13543784.16.12.1955] with high uroselectivity. It appears to be more effective than tamsulosin in relieving urinary symptoms associated with benign prostatic hyperplasia (BPH).Fact|date=August 2008

History

Silodosin received its first marketing approval in Japan in May 2006 under the tradename Urief, which is jointly marketed by Kissei Pharmaceutical Co., Ltd. and Daiichi Sankyo Pharmaceutical Co., Ltd.

Kissei licensed the US, Canadian, and Mexican rights for silodosin to Watson Pharmaceuticals, Inc. in 2004.

On February 12, 2008, Watson announced that the New Drug Application submitted to the United States Food and Drug Administration for silodosin has been accepted for filing. FDA approved this drug on October 9th, 2008. [cite web |url=http://www.drugs.com/nda/silodosin_080212.html |title=Drugs.com, Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia |accessdate=2008-02-13 |format= |work= ]

References

External links

* [http://ir.watsonpharm.com/phoenix.zhtml?c=65778&p=irol-newsArticle&ID=719690&highlight= Watson Pharm., Inc.- Press Release]
* [http://www.medscape.com/viewarticle/548919 Medspace.com atricle]


Wikimedia Foundation. 2010.

Look at other dictionaries:

  • Silodosin — Strukturformel Allgemeines Freiname Silodosin Andere Namen …   Deutsch Wikipedia

  • Doxazosin — Systematic (IUPAC) name (RS) 2 {4 [(2,3 dihydro 1,4 benzodioxin 2 yl)carbonyl]piperazin 1 yl} 6,7 dimethoxyquinazolin 4 amine Clinical data Trade names …   Wikipedia

  • Tamsulosin — Systematic (IUPAC) name (R) 5 (2 {[2 (2 ethoxyphenoxy)ethyl]amino}propyl) 2 methoxybenzene 1 sulfonamide Clinical data …   Wikipedia

  • Guanethidine — Systematic (IUPAC) name 2 [2 (azocan 1 yl)ethyl]guanidine Clinical data AHFS/Drugs.com …   Wikipedia

  • Amphetamine — For other uses, see Amphetamine (disambiguation). Amphetamine Systematic (IUPAC) name …   Wikipedia

  • Dimethyltryptamine — Systematic (IUPAC) name 2 (1H indol 3 yl) N …   Wikipedia

  • Epinephrine — Adrenaline and Adrenalin redirect here. For other uses, see Adrenaline (disambiguation). (R) (–) L Epinephrine or (R) (–) L adrenaline …   Wikipedia

  • Monoamine oxidase inhibitor — MAOI redirects here. For the Easter Island statues, see Moai. Monoamine oxidase Monoamine oxidase inhibitors (MAOIs) are a class of antidepressant drugs prescribed for the treatment of depression. They are particularly effective in treating… …   Wikipedia

  • Phenothiazine — Phenothiazine …   Wikipedia

  • Clozapine — Not to be confused with clonazepam or Klonopin. Clozapine Systematic (IUPAC) name …   Wikipedia


Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.